
1. raltegravir.

livertox: clinical research information drug-induced liver injury
[internet]. bethesda (md): national institute diabetes digestive and
kidney diseases; 2012-.
2018 jan 30.

raltegravir integrase inhibitor, first class antiviral agents
active human immunodeficiency virus (hiv) targets viral
integrase. raltegravir used combination antiretroviral agents in
the treatment hiv infection. raltegravir linked convincingly to
serum aminotransferase elevations therapy episodes acute,
clinically apparent liver injury.

pmid: 31643636 

